Guangji Pharmaceutical Reports Operation Revenue of RMB 462 Million for the First Three Quarters of 2024, Down 11.54% Year-on-Year
Continue reading with Effamall membership.
Already a member? Login here.
Tag:
Copy Link
<Prev
Next>
<Prev
Next>
